… benefit from high dose bronchodilator therapy given by a spacer device or by home
nebulizer. Domiciliary trials will identify optimal bronchodilator treatment for individual patients. …

… , including some preparations of albuterol, contain either BAC … For example, a standard
2.5-mg dose of albuterol nebulizer … and withdraw bronchodilator nebulizer solutions that contain …

… bronchodilator administered with IPPB was no different from that following bronchodilator
administered by an oxygen-driven nebulizer. On … of use in bronchodilator therapy of pulmonary …

… of bronchodilator therapy with nebulizers and inhalers. Prospective, long-term clinical trials
using long-acting bronchodilators, … airflow limitation) found albuterol via nebulizer and inhaler …

… We found that the amount of albuterol trapped in the nebulizer is nearly 50% greater than
that estimated by gravimetric methods. These results agree with those of O'Callaghan et al, 7 …

… therapy with high-dose albuterol … bronchodilator therapies because of the relatively small
number of patients enrolled in their study. Nonsignificant trends favoring combination therapy …

… In chronic obstructive pulmonary disease (COPD) the clinical efficacy of bronchodilator
therapy delivered via a nebulizer versus an aerochamber on FEV 1 is controversial. No studies …

… as pulmonary ventilation and aeration through changes in conductivity of the tissues, as
well as inhaled bronchodilator therapy during invasive MV in critically ill patients [12,13,30]. …

… of a novel therapy. There was no standardized method of reporting adverse events in
response to nebulized therapies in our center. We created a new process for respiratory therapy …

… are major targets for bronchodilator therapy. Bronchodilation can be achieved through 2 …
that when we tried to transition away from nebulizer therapy in the hospital to a pMDI with a …